These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12543197)

  • 1. Immunohistochemical study of epiretinal proliferative cellular tissue from a patient with sarcoidosis.
    Fukushima A; Hashida M; Hayashi N; Hiroi M; Ueno H
    Jpn J Ophthalmol; 2002; 46(6):675-8. PubMed ID: 12543197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis.
    Kojima K; Maruyama K; Inaba T; Nagata K; Yasuhara T; Yoneda K; Sugita S; Mochizuki M; Kinoshita S
    Ophthalmology; 2012 Nov; 119(11):2386-92. PubMed ID: 22809758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological findings in proliferative membrane from a patient with sarcoid uveitis.
    Miyao A; Ikeda T; Matsumoto Y; Uchida K; Machida T; Hongo M; Kinoshita S
    Jpn J Ophthalmol; 1999; 43(3):209-12. PubMed ID: 10413255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of vitreous specimens for uveitis classification: a prospective multicentre observational study.
    Maruyama K; Inaba T; Sugita S; Ichinohasama R; Nagata K; Kinoshita S; Mochizuki M; Nakazawa T
    BMJ Open; 2017 Nov; 7(11):e014549. PubMed ID: 29150462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indocyanine green-assisted peeling of the epiretinal membrane in proliferative vitreoretinopathy.
    Sakamoto H; Yamanaka I; Kubota T; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):204-7. PubMed ID: 12644944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study.
    Ueno A; Enaida H; Hata Y; Hisatomi T; Nakamura T; Mochizuki Y; Sakamoto T; Ishibashi T
    Eur J Ophthalmol; 2007; 17(3):392-8. PubMed ID: 17534822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epiretinal membranes: reasons not to perform vitreoretinal surgery].
    Bonnel S; Barale PO; Laroche L; Sahel JA; Monin C
    J Fr Ophtalmol; 2008 Feb; 31(2):200-7. PubMed ID: 18401323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of intraocular lesions using vitreous humor and intraocular perfusion fluid cytology: Experience with 83 Cases.
    Kinoshita Y; Takasu K; Kobayashi TK; Yuri T; Tsubura A; Shikata N
    Diagn Cytopathol; 2015 May; 43(5):353-9. PubMed ID: 25334001
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Goto H; Usui Y; Umazume A; Uchida K; Eishi Y
    Br J Ophthalmol; 2017 Nov; 101(11):1510-1513. PubMed ID: 28270483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis.
    Maruyama K; Inaba T; Tamada T; Nakazawa T
    Medicine (Baltimore); 2016 Dec; 95(49):e5531. PubMed ID: 27930546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of fibroblasts in experimental modeling of proliferative vitreoretinopathy].
    Khoroshilova-Maslova IP; Leparskaya NL; Vorotelyak EA; Vasiliev AV
    Vestn Oftalmol; 2017; 133(5):4-10. PubMed ID: 29165406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of proliferative sarcoid retinopathy with sarcoid nodules in tissue obtained during vitrectomy].
    Ogawa A; Sato Y; Miyasaka S; Fujita K; Shimada H; Kinukawa N
    Nippon Ganka Gakkai Zasshi; 2000 Mar; 104(3):174-8. PubMed ID: 10752341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
    Cao J; Wu L; Zhang H
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
    Sonoda KH; Enaida H; Ueno A; Nakamura T; Kawano YI; Kubota T; Sakamoto T; Ishibashi T
    Br J Ophthalmol; 2003 Aug; 87(8):1010-4. PubMed ID: 12881346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage studies in uveitis patients without radiological intrathoracic involvement of sarcoidosis.
    Sugimoto M; Nakashima H; Ando M; Kohrogi H; Araki S
    Jpn J Med; 1989; 28(1):50-4. PubMed ID: 2524616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.
    Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ
    Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.